Onto Innovation stock has delivered a very strong 409.3% return over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a premium rather than a clear bargain.

• Onto Innovation’s 409.3% five year gain highlights how much optimism is already reflected in the share price.
• The recent $720 million investment for a 27% stake in Rigaku Holdings, aimed at next generation semiconductor X-ray technologies, can support growth expectations. However, any setback in AI related demand or profitability may weigh heavily on what investors are willing to pay.
• The stock scores 0 out of 6 on Simply Wall St’s broader valuation checks, which suggests Onto Innovation does not screen as cheap on this framework 0/6 valuation score.

The issue now is whether Onto Innovation’s current price already more than reflects its growth story and recent news flow or still leaves room relative to its intrinsic value estimate.

Has Onto Innovation Run Too Far on Cash Flow?

The Discounted Cash Flow (DCF) model uses projected future cash flows to estimate what Onto Innovation shares might be worth today. For Onto Innovation, the latest twelve-month free cash flow sits at about $237.7 million, and the model assumes growing cash flows over time based on analyst forecasts followed by more moderate estimates.

On this basis, the DCF model points to an intrinsic value of about $287 per share in dollar terms. Compared with the current share price, this implies the stock appears to be around 22.3% overvalued rather than offering a clear discount. Onto Innovation’s recent $720 million investment for a 27% stake in Rigaku is a sizeable cash commitment, and the current premium suggests investors are already factoring in substantial potential benefit from that partnership.

Overall, the discounted cash flow analysis indicates that Onto Innovation currently appears overvalued relative to its modeled intrinsic value.

Our Discounted Cash Flow (DCF) analysis suggests Onto Innovation may be overvalued by 22.3%. Discover 53 high quality undervalued stocks or create your own screener to find better value opportunities.

Is Onto Innovation Getting Expensive on Earnings?

P/E is a useful yardstick for Onto Innovation because earnings are a key driver of how investors frame the stock today. Onto Innovation trades on a P/E of about 130.0x, compared with the wider semiconductor industry average of about 53.6x and a peer group average near 54.9x. That is more than double the sector backdrop for similar earnings streams.

The Simply Wall St model suggests a tailored fair P/E of about 49.5x for Onto Innovation, based on its growth profile, margins, size and risk. The gap between this fair ratio and the current 130.0x implies investors are paying a very full price for each dollar of earnings, even after factoring in the Rigaku partnership and AI related demand highlighted in recent news.

On this P/E multiple, Onto Innovation stock appears overvalued relative to both its own modeled fair ratio and industry benchmarks.

The Onto Innovation Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Onto Innovation pick up where the DCF and P/E checks leave off and spell out what would need to happen with Onto Innovation's growth, margins and earnings for today’s valuation to look comfortably high or too low. Rather than relying on a single multiple or model output, each Narrative lays out the assumptions behind its view of fair value so you can compare those expectations with actual results as they arrive, and they sit on Simply Wall St's Community page.

Community views on Onto Innovation have split into two very different stories about what the current price is really baking in.

Bull case: 8% undervalued

"Onto Innovation is emerging as one of the most strategically important semiconductor equipment companies in the AI supply chain, while much investor attention remains focused on GPU manufacturers and memory suppliers..."

Bear case: 6% overvalued

"Rising geopolitical pressures, regulatory demands, and supply chain localization are increasing Onto Innovation's costs and constraining long-term profitability potential..."

Do you think there's more to the story for Onto Innovation? Head over to our Community to see what others are saying!

The Bottom Line

Onto Innovation screens as overvalued on both the Discounted Cash Flow (DCF) intrinsic value estimate and current market multiples, and the broader checks do not flag it as a value opportunity. The recent move and premium valuation leave less margin for error if cash flow growth, AI related demand or benefits from the Rigaku deal fall short of expectations. For you as an investor, the key question from here is whether Onto Innovation can sustain the kind of growth and profitability that would make today’s valuation feel normal rather than stretched.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.